CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

Transcription

1 3QFY19 Result Update February 05, 2019 Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572 Strong Performance with Positive Outlook; Maintain (ATL) has reported strong volume performance in 3QFY19. Its consolidated revenue grew by 17% YoY and 11% QoQ to Rs47.2bn (vs. our estimate of Rs45.8bn) primarily led by 11% YoY volume growth and 5% YoY improvement in pricing. EBITDA rose by 6% YoY and 13% QoQ to Rs5.3bn led by better product-mix and healthy volume, despite >300bps negative impact of higher RM cost. EBITDA margin stood at 11.2% (-108bps YoY and +20bps QoQ) vs. our estimate of 12%. Net profit adjusted for exceptional loss of Rs0.6bn on investment in IL&FS deposits surged by 32% QoQ (flat on YoY basis) to Rs2.45bn vs. our estimate of Rs2.2bn. Notably, ATL s capacity expansion programme is also moving as per the schedule and the Management expects the growth momentum to continue, going forward as well with the healthy replacement demand, despite slowdown in OEM segment. Moreover, anti-dumping duty in Europe started benefitting the Company in Europe. Ramp-up at European operation and inter transfer of production is expected to aid further improvement in margin. Healthy Growth in Domestic Volume Aided Top-line Led by >11% YoY growth in volume, ATL s consolidated revenue grew by a strong 17% YoY and 11% QoQ, while standalone revenue rose by 17% YoY and 1% QoQ to Rs31.2bn. OEM volume remained muted due to subdued sales by the OEMs during festive season, while replacement segment grew by a healthy double-digit. TBR volume grew by >20% YoY, while overall truck replacement volume growth came in at ~12% YoY. European volume grew by high single-digit as against industry decline. The Company gained market share across segments in India and Europe and it is in the process of expanding capacity in both geographies. Its inventory is ~1 week higher than usual due to lower demand from the OEMs. It plans capex of Rs15bn and Rs30bn in FY19E and FY20E, respectively. Operating Margins to Improve ATL s EBITDA margins grew by 20bps QoQ (-108bps YoY) due to higher RM cost and pricing pressure. In Jan 19, ATL rolled back the price hike taken in Nov 18 due to competitive pressure. However, it expects margin improvement with lower commodity cost and improving mix in India. Moreover, it expects European operation to witness margin expansion with higher utilisation. Outlook & Valuation Looking ahead, we expect ATL s performance to improve owing to steady ramp-up in Hungarian operations and market share gain across both the geographies. In view of market share gain, we increase our revenue estimates by 2%/4% and reduce our EBIDTA estimates by 6%/4% assuming margin pressure for FY20E/FY21E. Factoring in higher depreciation for higher capex and interest expenses for increasing debt level, we cut our EPS estimates by 11%/7% for FY20E/ FY21E. Considering ATL s outperformance in tyre industry and improving market share, we maintain its P/E valuation multiple at 12x. Expecting ATL s earnings to clock 19% CAGR over FY19-FY21E and valuing it at 12xFY21E EPS, we maintain our recommendation on the stock with a revised Target Price of Rs250 (from Rs270 earlier). Share price (%) 1 mth 3 mth 12 mth Absolute performance (12.5) (5.3) (19.2) Relative to Nifty (14.2) (9.0) (21.5) Shareholding Pattern (%) Sep-18 Dec-18 Promoter Public Key Financials Y/E Mar (Rsmn) FY19E FY20E FY21E Net Sales 178, , ,572 EBITDA 20,250 23,951 27,638 EBITDA margin (%) Adj. Net Profit 8,846 10,028 11,918 EPS(Rs.) PER (x) EV/ EBITDA RoE (%) of Estimates (% change) FY20E FY21E Cons Revenue 2 4 EBITDA (6) (4) Net profit (11) (7) EPS (Rs) (11) (7) 1 Year Stock Price Performance Quarterly Performance YE March (Rs. mn) 3QFY19 3QFY18 YoY (%) 2QFY19 QoQ (%) Total Revenue 47,183 40, , EBIDTA 5,273 4, , Profit Before Tax 2,508 3,503 (28.4) 1, Less: Total Tax 529 1,050 (49.6) PAT 1,979 2,453 (19.3) 1, Adj. PAT 2,453 2, , Adj EPS (Rs) EBIDTA Margin (%) (108) bps bps Adj NPM (%) (86) bps bps Source: Company, RSec Research Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Jan-19 Note: * CMP as on February 05, 2019 Research Analyst: Mitul Shah Contact: mitul.shah@relianceada.com 1

2 Risk to the view Intensifying competition. in government regulation. Sharp up-tick in input prices. Significant slump in OEM sales in India/Europe. Exhibit 1: Result Summary (Consolidated) YE March (Rs mn) 3QFY19 3QFY18 YoY (%) 2QFY19 QoQ (%) Total Revenue 47,183 40, , Less: Net Raw Material consumed 27,853 22, , Other Expenses 7,573 7,632 (0.8) 7,598 (0.3) Personnel 6,485 5, , Total Expenditure 41,910 35, , EBIDTA 5,273 4, , Less: Depreciation 2,011 1, , EBIT 3,262 3,450 (5.4) 2, Less: Interest Add: Other income (28.5) Extraordinary Expense (net) (600) 0 NM (400) NM Profit Before Tax 2,508 3,503 (28.4) 1, Less: Total Tax 529 1,050 (49.6) Profit After Tax 1,980 2,453 (19.3) 1, Adj. PAT 2,453 2, , Reported EPS (Rs) (19.3) Adj. EPS (Rs) Cost & Margin Analysis (%) EBIDTA Margin (108) Adj. NPM (86) Eective Tax Rate (888) 26.0 (485) Cost Analysis RM/Net Sales Other Expenses (279) 17.8 (180) Personnel/Net Sales (52) Source: Company, RSec Research, *NM: Not Meaningful 2

3 Exhibit 2: Result Summary (Standalone) YE March (Rs mn) 3QFY19 3QFY18 YoY (%) 2QFY19 QoQ (%) Net Sales 31,232 26, , Less: Net Raw Material consumed 20,960 16, , Other Expenses 5,048 4, ,405 (6.6) Personnel 1,801 1, ,899 (5.1) Total Expenditure 27,809 23, , EBIDTA 3,423 3,667 (6.7) 3,724 (8.1) Less: Depreciation 1, ,070 (0.1) EBIT 2,354 2,777 (15.2) 2,654 (11.3) Less: Interest Add: Other income (36.0) Extraordinary Expense (net) (600) 0 NM (400) NM Profit Before Tax 1,651 2,852 (42.1) 2,026 (18.5) Less: Total Tax (48.2) 558 (24.6) Profit After Tax 1,230 2,040 (39.7) 1,468 (16.2) Adj. PAT 1,677 2,040 (17.8) 1,758 (4.6) Reported EPS (Rs.) (39.7) 2.57 (16.2) Adj. EPS (Rs.) (17.8) 3.07 (4.6) Cost and Margin Analysis (%) EBIDTA Margin (278) 12.0 (102) Adj. NPM (227) 5.7 (29) Eective Tax Rate (300) 27.5 (204) Cost Analysis RM/Net Sales Other Expenses./Net Sales (212) 17.4 (122) Personnel/Net Sales (59) 6.1 (34) Source: Company, RSec Research,*NM: Not Meaningful Exhibit 3: Revised vs. Old Estimates Old Revised % change Y/E Mar (Rs mn) FY19E FY20E FY21E FY19E FY20E FY21E New Old % change Cons revenue 177, , , , , , EBITDA 20,935 25,544 28,647 20,250 23,951 27,638 (3) (6) (4) EBITDA margin (%) Net profit 8,724 11,233 12,870 8,846 10,028 11,918 1 (11) (7) EPS (Rs) (11) (7) Source: RSec Research 3

4 Profit & Loss Statement Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E Net revenue 148, , , ,572 Expenditure 131, , , ,934 Raw Materials 83, , , ,426 Employee Expenses 21,567 25,082 28,343 32,311 Other expenditure 26,227 30,194 35,202 39,197 EBITDA 16,657 20,250 23,951 27,638 Depreciation and amortization expense 5,926 7,851 9,105 10,332 EBIT 10,732 12,399 14,846 17,306 Non-operating income 980 1,169 1,234 1,465 Interest including finance charges 1,774 1,944 2,886 3,091 Adjusted pre-tax profit 9,938 11,624 13,194 15,680 Extra Ordinary Exp (186) 1, Reported pre-tax profit 10,124 10,624 13,194 15,680 Less: taxes 2,885 2,539 3,167 3,763 Reported net profit 7,239 8,085 10,028 11,917 Less: minority/associate earnings - (0) (1) (1) Reported net profit for shareholders 7,239 8,085 10,028 11,918 Adjusted net profit for shareholders 7,106 8,846 10,028 11,918 EPS (Rs), based on fully diluted shares Fully diluted shares outstanding (mn) Balance Sheet Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E Equity capital Reserves and surplus 97, , , ,712 Total equity 97, , , ,284 Deferred tax liability (net) 16,188 16,188 16,188 16,188 Total borrowings 46,612 46,612 51,273 43,582 Current liabilities 40,011 46,053 51,210 56,632 Total liabilities 200, , , ,686 Cash and cash equivalents 5,992 11,323 5,736 7,945 Inventory 29,454 34,580 39,348 44,479 Trade receivables 14,350 16,911 19,511 22,110 Total current assets 49,796 62,814 64,595 74,533 Gross block 174, , , ,547 Less: depreciation and amortization 70,226 89, , ,274 Add: capital work-in-process 23,041 22,500 25,500 12,750 Total fixed assets 127, , , ,024 Investments 13,425 15,425 15,425 15,425 Other assets 10,285 11,535 12,620 13,704 Total assets 200, , , ,686 4

5 Cash Flow Statement Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E Operating cashflow Pre-tax income 10,123 10,624 13,194 15,680 Add: depreciation and amortization 5,926 7,851 9,105 10,332 Add: interest expense (net) 1,295 1,944 2,886 3,091 Less: other adjustments (836) 11,128 5,753 7,879 Less: taxes paid (2,465) (2,539) (3,167) (3,763) Add: working capital changes 3,154 (2,896) (3,296) (3,390) Total operating cashflow 17,197 26,112 24,475 29,829 Investing cashflow Capital expenditure (29,386) (15,000) (30,000) (15,000) Investments (9,250) (2,000) - - Others (273) Total investing cashflow (38,908) (17,000) (30,000) (15,000) Financing cashflow Share issuances 14, Loans 11,608-4,661 (7,691) Dividend (1,838) (1,838) (1,838) (1,838) Interest Payment (1,323) (1,944) (2,886) (3,091) Total financing cashflow 24,395 (3,782) (62) (12,620) Net change in cash 2,683 5,330 (5,588) 2,209 Opening cash 3,309 5,992 11,323 5,736 Closing cash 5,992 11,322 5,735 7,944 Key Ratio Y/E Mar FY18 FY19E FY20E FY21E Growth Ratios (%) Net revenue EBITDA (10.6) Adjusted net profit (33.7) Ratios (%) Eective tax rate EBITDA margin Adjusted net income margin ROaCE ROaE Total asset turnover ratio (x) Inventory days Debtor days Creditor days Per share numbers (Rs) Diluted earnings Free cash (21.3) 19.4 (9.7) 25.9 Book value P/E EV/EBITDA P/B

6 Rating History Date Reco CMP TP 08-Jan Aug May Feb Nov Sep PLEASE CLICK HERE FOR PREVIOUS REPORTS Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE ; BSE - INB / INF / INE , Depository Participants: CDSL IN-DP IN-DP-NSDL , Research Analyst: INH ); AMFI ARN No